SMARCB1 and rhabdoid tumor: Molecular characterization of SCU HBs revealed that a proportion of HBs with SCU histology are actually primary rhabdoid tumors with characteristic loss-of-function variants or deletions of the SMARCB1 gene, loss of INI1 [7,8], low AFP levels, and poor outcomes [9].